Identifying patient-specific beliefs and behaviours for conversations about adherence in asthma
JM Foster, L Smith, SZ Bosnic-Anticevich, T Usherwood, SM Sawyer, CS Rand, HK Reddel
Internal Medicine Journal | WILEY | Published : 2012
Funding and conflict of interest: Dr Foster has received a research grant from GlaxoSmithKline and AstraZeneca and lecture fees from GlaxoSmithKline, Pharmaceutical Society of Australia and AstraZeneca. Dr Smith has received a research grant from Novo Nordisk and lecture fees from Pharmaceutical Society of Australia. Prof Sawyer has participated in an advisory board for Astra Zeneca. Prof. Rand has participated in advisory boards for TEVA and received consultancy fees for TEVA and Merck. A/Prof. Reddel has participated in advisory boards for AstraZeneca and Novartis, received consultancy fees from GlaxoSmithKline, lecture fees from AstraZeneca, Getz Pharma and MSD, research grants from AstraZeneca and is participating in a data monitoring committee for AstraZeneca, GlaxoSmithKline Merck and Novartis. Dr Bosnic-Anticevich and Prof. Usherwood have no potential conflicts of interest with respect to this article. Funding for this study was provided by Asthma Foundation NSW. Support for J.M.F.'s salary was provided in the form of an unrestricted research grant from AstraZeneca Australia. Medication was provided by GlaxoSmithKline. The Asthma Control Test was used with permission of GlaxoSmithKline and in accordance with conditions specified by GlaxoSmithKline under the terms of its license with the copyright holder, QualityMetric Incorporated. Smartinhalers were purchased from Nexus6, Auckland, New Zealand. None of the above bodies had any role in the design, conduct, analysis or interpretation of the study, and they did not see the manuscript prior to submission. The authors alone are responsible for the content and writing of the paper.